Non Clinical Trials Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 October 27
SKU : OT6783
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
FAQ’s
What is the Projected CAGR value of the Non-Clinical Trials Market ?
Non-Clinical Trials Market is expected to grow at a CAGR of 4.5% during the forecast period 2023-2030.
Who are the key players in Non-Clinical Trials Market ?
Major players are Charles River Laboratories, PPD (Pharmaceutical Product Development), ICON plc, Novartis AG, Merck & Co., Inc., AstraZeneca plc, CMIC HOLDINGS Co., LTD, ProPharma, MorphoSys AG and Labcorp Drug Development.
Related Reports
pharmaceuticalsClinical Trials Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 May 13
Starting from
$5350
healthcare-itClinical Trial Management System Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 May 14
Starting from
$5350
healthcare-services
Virtual Clinical Trials Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 May 17
Starting from
$4350
pharmaceuticalsPediatric Clinical Trails Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 08
Starting from
$4350
biotechnologyClinical Microbiology Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
healthcare-itClinical Decision Support System Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350